Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Dawson

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
Journal of Medicinal Chemistry|June 2, 2026
Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria ParasitesBarbara Forte, Fiona Bellany, Peter S Campbell, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
Journal of Medicinal Chemistry|June 2, 2026
Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria ParasitesBarbara Forte, Fiona Bellany, Peter S Campbell, et al.
Pageof 6